Colostrupedics is the first animal-free infant formula comprising cell-cultured human milk molecules derived from human mammary cell agriculture and formulated with broadly-neutralizing human secretory antibodies.
Since 2013, 108Labs has worked on mammary cell agriculture by developing the first infant formula biosimilar to mother’s milk with secretory antibodies.
"Whole-human" infant formula is made with human molecules produced with human cells. It is formulated with patent-pending human cell-cultured ingredients comprising complex sugars, probiotic HMO, bioactive human proteins, and calorically-dense human lipids naturally evolved in mothers.
The company said its whole-human infant formula contains a healthier amino-acid pattern, fully human protein sequences, and human oligosaccharides missing from bovine formula.
"After a long journey, it is an exciting day to emerge with such an innovative product vision and major scientific milestones behind us,” said Shayne Giuliano, co-founder and CEO of 108Labs.
“108Labs has long dreamed of a day when mothers do not have to compromise on nutritional or antimicrobial benefits when deciding how to feed their newborns. Launching Colostrupedics whole-human infant formula with the world’s first human secretory antibody ingredient is a major step in our mission to replace bovine with healthier whole-human milk worldwide by 2040."
108Labs is running pre-clinical safety and efficacy studies in preparation for infant nutritional trials with 108Labs’ Colostrupedics whole-human infant formula.